ABIOMED, Inc. (ABMD)

Check out top investors' recommendation for ABMD
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
186.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The company’s products are designed to enable the heart to rest, heal, and recover by enhancing blood flow and/or performing the pumping function of the heart. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with an integrated motor and sensors for use in interventional cardiology; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the AB5000 Circulatory Support System and the BVS 5000 Biventricular Support System for the temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. Its products are used in the cardiac catheterization lab by interventional cardiologists and/or in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during, or after angioplasty or heart surgery procedures. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is based in Danvers, Massachusetts.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Greg Simpson Wunderlich Securities, Inc. Buy   Nov 28, '12   14.17  29.00  Nov 28, '13  101.48% 
Thomas Gunderson Piper Jaffray Buy   Nov 27, '12   14.65  18.00  Nov 27, '13  92.56% 
Suraj Kalia Northland Sec Sell   Oct 17, '12   20.64  14.00  Oct 17, '13  32.17% 
Raj Denhoy Jefferies & Co. Buy   Sep 05, '12   22.72    Sep 05, '13  5.94% 
Bob Hopkins BofA Merrill Lynch Sell   Aug 28, '12   22.51  21.00  Aug 28, '13  6.71% 
Greg Simpson Wunderlich Securities, Inc. Buy   May 16, '12   23.22  29.00  May 16, '13  0.00% 
Greg Simpson Wunderlich Securities, Inc. Buy   Jan 31, '12   18.50  24.00  Jan 31, '13  29.73% 
Greg Simpson Wunderlich Securities, Inc. Buy   Dec 11, '11   20.59  24.00  Dec 11, '12  16.56% 
Greg Simpson Wunderlich Securities, Inc. Buy   Nov 01, '11   14.33  24.00  Nov 01, '12  67.48% 
Raj Denhoy Jefferies & Co. Buy   Apr 10, '11   16.07  18.00  Apr 10, '12  27.32% 
Greg Simpson Wunderlich Securities, Inc. Buy   Apr 03, '11   14.88  18.00  Apr 03, '12  49.13% 
Greg Simpson Wunderlich Securities, Inc. Buy   Dec 08, '10   9.25  14.00  Dec 08, '11  115.24% 
12next >